177 related articles for article (PubMed ID: 27088959)
1. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
Khatri ML
Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the therapeutic benefit of dexamethasone cyclophosphamide pulse versus only oral cyclophosphamide in phase II of the dexamethasone cyclophosphamide pulse therapy: a preliminary prospective randomized controlled study.
Parmar NV; Kanwar AJ; Minz RW; Parsad D; Vinay K; Tsuruta D; Ishii N; Hashimoto T
Indian J Dermatol Venereol Leprol; 2013; 79(1):70-6. PubMed ID: 23254732
[TBL] [Abstract][Full Text] [Related]
3. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
4. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris.
Sethy PK; Khandpur S; Sharma VK
Indian J Dermatol Venereol Leprol; 2009; 75(5):476-82. PubMed ID: 19736426
[TBL] [Abstract][Full Text] [Related]
5. Outcome of dexamethasone-cyclophosphamide pulse therapy in pemphigus: a case series.
Kandan S; Thappa DM
Indian J Dermatol Venereol Leprol; 2009; 75(4):373-8. PubMed ID: 19584462
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the duration of phase I of dexamethasone - cyclophosphamide pulse therapy.
Nayak CS; Ray S; Thombre A; Jain M
Indian J Dermatol Venereol Leprol; 2014; 80(4):296-9. PubMed ID: 25035352
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-cyclophosphamide pulse therapy in pemphigus: a review of 72 cases.
Zivanovic D; Medenica L; Tanasilovic S; Vesic S; Skiljevic D; Tomovic M; Nikolic MM
Am J Clin Dermatol; 2010; 11(2):123-9. PubMed ID: 20141233
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
Kanwar AJ; Kaur S; Thami GP
Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
[TBL] [Abstract][Full Text] [Related]
9. Current regimen of pulse therapy for pemphigus: minor modifications, improved results.
Pasricha JS;
Indian J Dermatol Venereol Leprol; 2008; 74(3):217-21. PubMed ID: 18583786
[TBL] [Abstract][Full Text] [Related]
10. Immediate and delayed complications of dexamethasone cyclophosphamide pulse (DCP) therapy.
Jain R; Kumar B
J Dermatol; 2003 Oct; 30(10):713-8. PubMed ID: 14684952
[TBL] [Abstract][Full Text] [Related]
11. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
[TBL] [Abstract][Full Text] [Related]
12. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone-cyclophosphamide pulse therapy outcomes comparing pemphigus vulgaris and pemphigus foliaceus groups in a Brazilian cohort study.
Fontenelle LF; Bueno-Filho R; Vernal S; Delfino R; Barbosa GSL; Donadi EA; Roselino AM
An Bras Dermatol; 2023; 98(6):774-780. PubMed ID: 37355353
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
15. Curative effect of dexamethasone-cyclophosphamide pulse therapy for the treatment of pemphigus vulgaris.
Pasricha JS; Das SS
Int J Dermatol; 1992 Dec; 31(12):875-7. PubMed ID: 1478770
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
Kaur S; Kanwar AJ
Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
[TBL] [Abstract][Full Text] [Related]
17. Cyclophosphamide pulses with oral prednisolone in the treatment of pemphigus: a pilot study.
Bhat R; Sharma VK; Ramam M; Kumar A
Dermatol Online J; 2005 Dec; 11(3):4. PubMed ID: 16409900
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
Sharma VK; Khandpur S
Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris.
Chams-Davatchi C; Esmaili N; Daneshpazhooh M; Valikhani M; Balighi K; Hallaji Z; Barzegari M; Akhyani M; Ghodsi SZ; Seirafi H; Nazemi MJ; Mortazavi H; Mirshams-Shahshahani M
J Am Acad Dermatol; 2007 Oct; 57(4):622-8. PubMed ID: 17583373
[TBL] [Abstract][Full Text] [Related]
20. Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients.
Gheisari M; Faraji Z; Dadras MS; Nasiri S; Robati RM; Moravvej H; Tehranchinia Z; Ghalamkarpour F; Namazi N; Nobari NN
Dermatol Ther; 2019 Sep; 32(5):e13057. PubMed ID: 31400243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
